---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-011091"
form_type: "8-K"
ticker: "COPL"
cik: "0002045473"
company_name: "Copley Acquisition Corp"
filed_at: "2026-10-13T21:00:48+00:00"
generated_at: "2026-10-13T21:02:04.180490+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Copley Acquisition terminates Ignite Proteomics merger; faces Nov 2, 2026 deal deadline

## Summary
- Mutual Termination Agreement dated Oct 9, 2026 ends the June 10, 2026 Business Combination Agreement with Ignite Proteomics, LLC effective immediately.
- Copley intends to keep pursuing a business combination; it has until Nov 2, 2026, subject to extension, and cites risk of trust-account redemption and liquidation.
- Only Sections 6.14, 6.15, 8.2, 9.1 and Article X of the BCA survive; all ancillary documents, including Seller Support Agreements, Insider Letter Amendment and Lock-Up Agreements, auto-terminated.
- Each party bears its own fees and expenses incurred on the deal; the Termination Agreement includes mutual releases of all BCA-related claims, other than claims under the Termination Agreement.

## SEC filing metadata
- accession: 0001829126-26-011091
- form_type: 8-K
- ticker: COPL
- cik: 0002045473
- company_name: Copley Acquisition Corp
- filed_at: 2026-10-13T21:00:48+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2045473/000182912626011091/0001829126-26-011091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2045473/000182912626011091/copleyacq_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-011091
- JSON: https://secwatch.observer/filing/0001829126-26-011091.json
- Plain text: https://secwatch.observer/filing/0001829126-26-011091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.